GSK Bioportal

• Research type

  Research Tissue Bank

• IRAS ID

  352665

• Research summary

  GSK Bioportal

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  25/EE/0004

• Date of REC Opinion

  28 Feb 2025

• REC opinion

  Further Information Favourable Opinion

• Data collection arrangements

  A wide variety of human biological samples (HBS) and associated relevant data (clinical and demographic) are
  needed by GSK and GSK collaborators for research purposes in to develop and validate new targets for
  treatment and new drugs.
  Such samples may be sourced from healthy volunteers as well as patients with defined diseases.
  Samples will either be sourced directly by GSK or in collaboration with NHS Trusts or NIHR Bioresource.
  All samples will have been collected with appropriate donor consent allowing research use and confidentiality of the
  donor will be maintained through sample coding or anonymisation. The key codes will not be available to those
  performing the research.
  

• Research programme

  GSK Bioportal intends to support a wide variety of research programs within GSK and in collaboration with external researchers. A range of analytical procedures employing human biological samples are performed on a routine basis at GSK to identify and validate biological targets for subsequent discovery and development of novel pharmaceutical and biopharmaceutical interventions. Therapeutic areas being addressed include but are not limited to respiratory, inflammatory and neurological diseases, and biopharmaceutical studies involving a broader range of therapeutic areas.

• Storage license

  12202

• RTBTitle

  GSK Bioportal

• Establishment organisation

  GSK Clinical Unit Cambridge

• Establishment organisation address

  ACCI, Box 128, Addenbrooke’s Hospital

  Hills Road

  Cambridge

  CB2 0QQ